Galmed Pharmaceuticals Lt...
(GLMD)
undefined
undefined%
At close: undefined
3.09
2.31%
Pre-market Jan 07, 2025, 04:46 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -6.91M | -17.87M | -32.47M | -28.77M | -20.46M | -9.86M | -12.30M | -16.95M | -10.62M | -9.10M | -17.48M | -3.15M |
| Depreciation & Amortization | 31.00K | 35.00K | 42.00K | 39.00K | 35.00K | 387.00K | 239.00K | 169.00K | 50.00K | 9.00K | 4.00K | 5.00K |
| Stock-Based Compensation | 892.00K | 1.30M | 1.89M | 2.07M | 2.23M | 1.78M | 1.39M | 1.63M | 970.00K | 601.00K | 10.85M | 208.00K |
| Other Working Capital | 468.00K | -140.00K | -275.00K | 54.00K | -750.00K | -538.00K | -1.35M | 1.71M | -223.00K | -28.00K | 38.00K | 60.00K |
| Other Non-Cash Items | -280.00K | 485.00K | 13.00K | -285.00K | -63.00K | -144.00K | -167.00K | 1.67M | 1.06M | 601.00K | 2.89M | 208.00K |
| Deferred Income Tax | n/a | n/a | 84.00K | -437.00K | -114.00K | 12.00K | 164.00K | -1.40M | -920.00K | -601.00K | n/a | -208.00K |
| Change in Working Capital | 132.00K | -2.45M | -2.45M | 1.10M | 3.44M | -1.21M | -1.40M | 2.75M | 986.00K | -748.00K | 1.22M | -143.00K |
| Operating Cash Flow | -6.14M | -18.50M | -32.89M | -26.29M | -14.94M | -9.02M | -12.07M | -12.13M | -8.47M | -9.24M | -2.52M | -3.08M |
| Capital Expenditures | n/a | -4.00K | -11.00K | -44.00K | -12.00K | -90.00K | -21.00K | -17.00K | -159.00K | -770.00K | -13.00K | -32.00K |
| Acquisitions | -1.50M | -17.57K | n/a | -24.94M | 21.80M | 6.08M | n/a | 13.00K | -6.00M | 8.25M | n/a | n/a |
| Purchase of Investments | -6.33M | -3.87M | -13.57M | -55.03M | -94.41M | -98.35M | -3.87M | -7.62M | -26.54M | -8.25M | n/a | n/a |
| Sales Maturities Of Investments | 8.63M | 21.44M | 25.04M | 71.61M | 101.10M | 38.42M | 10.32M | 13.96M | 15.59M | -2.25M | n/a | n/a |
| Other Investing Acitivies | n/a | 17.57K | -1K | 24.94M | -21.80M | -6.08M | 9.00K | 13.00K | 6.00M | -6.00M | 16.00K | n/a |
| Investing Cash Flow | 800.00K | 17.56M | 11.46M | 16.54M | 6.68M | -60.02M | 6.44M | 6.34M | -11.11M | -9.02M | 3.00K | -32.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.82M | 20.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a | 61.00K | 143.00K | 1.03M | 530.00K | 255.00K | n/a | n/a | n/a | 3.66M |
| Financial Cash Flow | 6.18M | 70.00K | 17.37M | 768.00K | 143.00K | 80.18M | 15.55M | 4.73M | n/a | 41.86M | 1.94M | 3.68M |
| Net Cash Flow | 848.00K | -868.00K | -4.06M | -8.98M | -8.12M | 11.14M | 9.92M | -1.06M | -19.58M | 23.60M | -581.00K | 572.00K |
| Free Cash Flow | -6.14M | -18.50M | -32.90M | -26.33M | -14.95M | -9.11M | -12.09M | -12.15M | -8.63M | -10.01M | -2.54M | -3.11M |